Every year, 12 million people worldwide suffer a stroke; many die or are permanently impaired. Currently, drugs are ...

A strategic and financial recalibration on psychiatric drug development brings profound implications for investors, insurers, ...

How sponsors can leverage technology to enhance, not hinder, site efficiency and usability Strategies to incorporate site ...

Century Therapeutics, Candel Therapeutics and MacroGenics have all used their third-quarter earnings releases to disclose how ...

The hope is using AI to judge outcomes will ease the high cost and complexity of running big clinical trials, say researchers.

Advarra and IgniteData have announced a new partnership, enabling secure clinical data transfer between research sites’ instances of Advarra's eSource and electronic data capture (EDC) solutions, ...

Cybin ( ($TSE:CYBN) ) has provided an update. Cybin Inc. reported its financial results for the second quarter of fiscal year 2026, highlighting a ...

As unforeseen circumstances complicate clinical trial operations, companies in the space must be flexible to reduce the ...

Experts reviewing decades of research conclude there is no scientific evidence that the gut microbiome causes autism.

These studies represent promising new treatment options for chronic and progressive kidney diseases, offering renewed hope to ...

The approval marks the start of human testing for the experimental vaccine, which is designed to strengthen immune protection in respiratory tract.

Ethicist Art Caplan discusses FDA layoffs and their impact on protection of human research subjects in clinical trials.